ExodusPoint Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.9M | Buy |
+177,661
| New | +$13.9M | 0.12% | 141 |
|
2025
Q1 | – | Sell |
-30,428
| Closed | -$2.25M | – | 1526 |
|
2024
Q4 | $2.25M | Buy |
+30,428
| New | +$2.25M | 0.02% | 621 |
|
2024
Q2 | – | Sell |
-188,747
| Closed | -$18M | – | 1506 |
|
2024
Q1 | $18M | Buy |
+188,747
| New | +$18M | 0.14% | 93 |
|
2023
Q4 | – | Sell |
-54,226
| Closed | -$3.76M | – | 1563 |
|
2023
Q3 | $3.76M | Buy |
+54,226
| New | +$3.76M | 0.04% | 419 |
|
2023
Q1 | – | Sell |
-9,762
| Closed | -$728K | – | 1754 |
|
2022
Q4 | $728K | Sell |
9,762
-138,438
| -93% | -$10.3M | 0.01% | 1028 |
|
2022
Q3 | $12.2M | Buy |
+148,200
| New | +$12.2M | 0.16% | 150 |
|
2021
Q4 | – | Sell |
-12,040
| Closed | -$1.36M | – | 2225 |
|
2021
Q3 | $1.36M | Buy |
12,040
+3,928
| +48% | +$445K | 0.02% | 845 |
|
2021
Q2 | $840K | Sell |
8,112
-52,233
| -87% | -$5.41M | 0.01% | 1025 |
|
2021
Q1 | $5.05M | Buy |
+60,345
| New | +$5.05M | 0.07% | 245 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 1993 |
|
2020
Q3 | – | Sell |
-29,187
| Closed | -$2.02M | – | 1811 |
|
2020
Q2 | $2.02M | Sell |
29,187
-693
| -2% | -$47.9K | 0.05% | 400 |
|
2020
Q1 | $1.88M | Buy |
29,880
+939
| +3% | +$59K | 0.1% | 161 |
|
2019
Q4 | $2.25M | Buy |
+28,941
| New | +$2.25M | 0.04% | 267 |
|
2019
Q3 | – | Sell |
-30,834
| Closed | -$1.9M | – | 1388 |
|
2019
Q2 | $1.9M | Sell |
30,834
-75,825
| -71% | -$4.67M | 0.08% | 142 |
|
2019
Q1 | $6.8M | Buy |
106,659
+77,679
| +268% | +$4.95M | 0.51% | 25 |
|
2018
Q4 | $1.48M | Buy |
+28,980
| New | +$1.48M | 0.1% | 60 |
|